Retrospective audit of antimicrobial prescribing practices for acute exacerbations of chronic obstructive pulmonary diseases in a large regional hospital

被引:6
作者
Brownridge, D. J. [1 ]
Zaidi, S. T. R. [2 ]
机构
[1] Ballarat Hlth Serv, Pharm Dept, Ballarat, Vic, Australia
[2] Univ Tasmania, Fac Hlth, Sch Med, Div Pharm, Private Bag 26, Hobart, Tas 7001, Australia
关键词
antibiotics; antimicrobial stewardship; appropriateness; chronic obstructive pulmonary disease; guideline adherence; COMMUNITY-ACQUIRED-PNEUMONIA; CEFTRIAXONE USE;
D O I
10.1111/jcpt.12514
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
What is known and objectiveChronic obstructive pulmonary disease (COPD) is associated with significant morbidity and mortality, and frequent exacerbations are associated with an increased risk of death, deterioration in lung function and reduced quality of life. Current Australian guidelines developed by the Lung Foundation of Australia (the COPD-X Plan) recommends the use of a short course of corticosteroids and oral antibiotics (amoxycillin or doxycycline) as part of the treatment of an AECOPD; however, it was noted that clinical practice at the study hospital had deviated from these guidelines. To evaluate the antibiotic prescribing practices in acute exacerbations of chronic obstructive pulmonary disease (AECOPD) patients, and to compare the differences in clinical outcomes (primarily mean length of stay and the rate of unplanned readmissions) between patients who received broad- vs. narrow-spectrum antibiotics in a large regional hospital. MethodsRetrospective audit of medical records for patients admitted with uncomplicated AECOPD during January-September, 2014 in a 224 acute bed regional hospital in Victoria, Australia. Results and discussionFifty-nine per cent of patients received broad-spectrum antibiotics (ceftriaxone), whereas only 10% of prescriptions were concordant with current Australian guideline recommendations. Patients receiving a broad-spectrum regimen were more likely to be older (749 vs. 699 years; P = 0009), have a higher COPD severity score (i.e. BAP-65 score, 155 vs. 106; P = 0002) and a higher CRP (592 vs. 255 mg/L; P = 0003) on admission. The mean LOS was not significantly different between those who received ceftriaxone and those who did not (509 vs. 455 days; P = 047). There was no significant difference between the groups in rates of readmissions. What is new and conclusionThe antibiotic prescribing patterns for AECOPD in rural and regional Australian hospitals have not previously been examined in the current literature. In the study hospital, the majority of patients received broad-spectrum antibiotics in the initial treatment of AECOPD. No differences in hospital length of stay, or rate of readmission for AECOPD were observed between those who received broad- and narrow-spectrum antibiotics.
引用
收藏
页码:301 / 305
页数:5
相关论文
共 20 条
  • [1] Clinical Pathway and Monthly Feedback Improve Adherence to Antibiotic Guideline Recommendations for Community-Acquired Pneumonia
    Almatar, Maher
    Peterson, Gregory M.
    Thompson, Angus
    McKenzie, Duncan
    Anderson, Tara
    Zaidi, Syed Tabish R.
    [J]. PLOS ONE, 2016, 11 (07):
  • [2] Factors influencing ceftriaxone use in community-acquired pneumonia: Emergency doctors' perspectives
    Almatar, Maher Ali
    Peterson, Gregory M.
    Thompson, Angus
    Zaidi, Syed Tabish R.
    [J]. EMERGENCY MEDICINE AUSTRALASIA, 2014, 26 (06) : 591 - 595
  • [3] [Anonymous], 2015, ANT PRESCR PRACT AUS
  • [4] Improving Outcomes in Elderly Patients With Community-Acquired Pneumonia by Adhering to National Guidelines Community-Acquired Pneumonia Organization International Cohort Study Results
    Arnold, Forest W.
    LaJoie, A. Scott
    Brock, Guy N.
    Peyrani, Paula
    Rello, Jordi
    Menendez, Rosario
    Lopardo, Gustavo
    Torres, Antoni
    Rossi, Paolo
    Ramirez, Julio A.
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2009, 169 (16) : 1515 - 1524
  • [5] Australian Institute of Health and Welfare, 2013, CAUS OF DEATH
  • [6] Provider Decisions to Treat Respiratory Illnesses with Antibiotics: Insights from a Randomized Controlled Trial
    Branche, Angela R.
    Walsh, Edward E.
    Jadhav, Nagesh
    Karmally, Rachel
    Baran, Andrea
    Peterson, Derick R.
    Falsey, Ann R.
    [J]. PLOS ONE, 2016, 11 (04):
  • [7] A European study on the relationship between antimicrobial use and antimicrobial resistance
    Bronzwaer, SLAM
    Cars, O
    Buchholz, U
    Mölstad, S
    Goettsch, W
    Veldhuijzen, IK
    Kool, JL
    Sprenger, MJW
    Degener, JE
    [J]. EMERGING INFECTIOUS DISEASES, 2002, 8 (03) : 278 - 282
  • [8] Calvert J, 2014, BRIT THORACIC SOC PH
  • [9] How to measure comorbidity: a critical review of available methods
    de Groot, V
    Beckerman, H
    Lankhorst, GJ
    Bouter, LM
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 2003, 56 (03) : 221 - 229
  • [10] Adherence to guideline-based antibiotic treatment for acute exacerbations of chronic obstructive pulmonary disease in an Australian tertiary hospital
    Fanning, M.
    McKean, M.
    Seymour, K.
    Pillans, P.
    Scott, I.
    [J]. INTERNAL MEDICINE JOURNAL, 2014, 44 (09) : 903 - 910